| Followers | 167 |
| Posts | 42756 |
| Boards Moderated | 3 |
| Alias Born | 10/20/2019 |
Friday, July 23, 2021 10:21:08 AM
I found this page of the website interesting and informative, to help me understand why this technology is so special.
https://www.rockwellmed.com/our-technology/technology-platform/
PLATFORM TECHNOLOGY TO MANAGE IRON IN A NEW WAY
Ferric pyrophosphate citrate (FPC) is a novel complex iron salt, developed to replace iron losses in patients with anemia in an entirely new way. This unique and differentiated molecule consists of an iron atom complexed to one pyrophosphate and two citrate anions. This formulation has been shown to allow for rapid donation of iron to transferrin, protein in the blood that binds to iron and transports it through the body, including to the bone marrow. This mechanism uses the body’s own means to transport iron safely to tissues that need iron (i.e. red blood cells and muscle).
https://www.rockwellmed.com/our-technology/technology-platform/
PLATFORM TECHNOLOGY TO MANAGE IRON IN A NEW WAY
Ferric pyrophosphate citrate (FPC) is a novel complex iron salt, developed to replace iron losses in patients with anemia in an entirely new way. This unique and differentiated molecule consists of an iron atom complexed to one pyrophosphate and two citrate anions. This formulation has been shown to allow for rapid donation of iron to transferrin, protein in the blood that binds to iron and transports it through the body, including to the bone marrow. This mechanism uses the body’s own means to transport iron safely to tissues that need iron (i.e. red blood cells and muscle).
Recent RMTI News
- Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis • Business Wire • 05/20/2026 10:00:00 AM
- Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis • Business Wire • 05/14/2026 10:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/11/2026 08:16:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 09:00:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 11:14:09 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 10:59:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 10:16:19 AM
- Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability • Business Wire • 05/07/2026 10:00:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/30/2026 01:00:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 10:59:07 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/20/2026 08:09:05 PM
- Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026 • Business Wire • 04/09/2026 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 11:30:28 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 11:01:16 AM
- Rockwell Medical tops earnings forecasts but shares slip on revenue decline • IH Market News • 03/26/2026 10:50:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 10:10:47 AM
- Rockwell Medical Announces Fourth Quarter and Full-Year 2025 Financial and Operational Results • Business Wire • 03/26/2026 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:11:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:10:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:10:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:09:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:08:43 PM
